Product Description
Mechanisms of Action: Calcium Binder
Novel Mechanism: Yes
Modality: Unknown
Route of Administration: Intravenous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Chinese Academy of Medical Sciences
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
ChiCTR2400083281 |
ChiCTR2400083281 | N/A |
Recruiting |
Kidney Transplant |
2024-10-31 |
2024-04-20 |
Treatments |